Barbara Cannon

COO, NuSirt Biopharma

Ms. Cannon currently serves as the Chief Operating Officer of NuSirt Biopharma in Nashville.  Barbara brings over 25 years clinical research experience to NuSirt Sciences. She was the CEO Alive Hospice, and was responsible for the start-up of ClinTrials Research, one of the early Clinical Research Organizations (CROs), providing outsourced clinical research services to the pharmaceutical industry. She was responsible for initiation of Phase II-IV research activities and participated in the company’s IPO, (NASDAQ:CCRO). Her role as CEO, and Board Director at Celeris Corporation (NASDAQ:CRSC) focused on supporting complex medical device, biologic, and combination FDA product approvals.

Ms. Cannon currently serves on several healthcare and financial services boards and holds an MBA from Northwestern University